Shelter Pharma (BOM:543963) Debt-to-EBITDA : 0.11 (As of Sep. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Shelter Pharma Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Shelter Pharma's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was ₹1.0 Mil. Shelter Pharma's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was ₹10.1 Mil. Shelter Pharma's annualized EBITDA for the quarter that ended in Sep. 2024 was ₹98.0 Mil. Shelter Pharma's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2024 was 0.11.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Shelter Pharma's Debt-to-EBITDA or its related term are showing as below:

BOM:543963' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -0.04 Med: 0.07 Max: 0.97
Current: 0.12

During the past 5 years, the highest Debt-to-EBITDA Ratio of Shelter Pharma was 0.97. The lowest was -0.04. And the median was 0.07.

BOM:543963's Debt-to-EBITDA is ranked better than
86.65% of 674 companies
in the Drug Manufacturers industry
Industry Median: 1.67 vs BOM:543963: 0.12

Shelter Pharma Debt-to-EBITDA Historical Data

The historical data trend for Shelter Pharma's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shelter Pharma Debt-to-EBITDA Chart

Shelter Pharma Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

Mar24

Debt-to-EBITDA

0.97

-0.04

0.05

0.25

0.07

Shelter Pharma Semi-Annual Data
	Mar20	Mar21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24
Debt-to-EBITDA	Get a 7-Day Free Trial			-	0.23	0.05	0.07	0.11

Competitive Comparison of Shelter Pharma's Debt-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Shelter Pharma's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shelter Pharma's Debt-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shelter Pharma's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Shelter Pharma's Debt-to-EBITDA falls into.

Save Embed

;

Save Embed

;

Shelter Pharma Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Shelter Pharma's Debt-to-EBITDA for the fiscal year that ended in Mar. 2024 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(0.041	+	5.732)	/	87.394
	=	0.07

Shelter Pharma's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2024 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(1.033	+	10.142)	/	97.97
	=	0.11

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is two times the quarterly (Sep. 2024) EBITDA data.

Shelter Pharma (BOM:543963) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

Shelter Pharma Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Shelter Pharma's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Shelter Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shelter Pharma Ltd (BOM:543963) » Definitions » Debt-to-EBITDA

Traded in Other Exchanges

N/A

Address

Opp. MJ Library Ashram Road, 5th Floor, 501 Sakar 4, Paldi, Ellisbridge, Ahmedabad, GJ, IND, 380006

Website

https://www.shelter.co.in

Shelter Pharma Ltd focuses in manufacturing herbal products with a well-built presence in Human Pharma as well as the Veterinary space. It is present in most of the non-critical segments of human and veterinary pharma through its well-spread portfolio. Its products include tablets, syrups, baby drops, barley water, oils, powders, ointments, etc.

Shelter Pharma Headlines

No Headlines